|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Research | |||||
| Consulting | |||||
| Events | |||||
| Total revenues | |||||
| Operating expenses: | |||||
| Cost of services and fulfillment | |||||
| Total cost of services and fulfillment | |||||
| Selling and marketing | |||||
| General and administrative | |||||
| Depreciation | |||||
| Amortization of intangible assets | |||||
| Integration costs | |||||
| Goodwill impairment | |||||
| Restructuring costs | |||||
| Loss from sale of divested operation | |||||
| Total operating expenses | |||||
| Income (loss) from operations | |||||
| Interest expense | |||||
| Other income, net | |||||
| Credit loss expense on note receivable | |||||
| Gains on investments, net | |||||
| Income (loss) before income taxes | |||||
| Income tax expense (benefit) | |||||
| Net income (loss) | |||||
| Basic income (loss) per common share | |||||
| Diluted income (loss) per common share | |||||
| Basic weighted average common shares outstanding | |||||
| Diluted weighted average common shares outstanding | |||||
Loading...